WESPAC Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
TA
TWM
FGA
AC
WESPAC Advisors's BTAL Position: Q4 2023 in Review
WESPAC Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 100,405 shares — an estimated $1.99M sold.
WESPAC Advisors first reported a position in BTAL in Q1 2023 and held it in 3 quarters. The position peaked at $2.13M in Q1 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.
- WESPAC Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
- WESPAC Advisors sold 100,405 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $1.99M.
- WESPAC Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 3 quarters.
- WESPAC Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $2.13M in Q1 2023.
- 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.
Based on WESPAC Advisors's 13F filing for Q4 2023, filed 26 Jan 2024.